A case study comparing a randomized withdrawal trial and a double-blind long-term trial for assessing the long-term efficacy of an antidepressant.

Mallinckrodt, Craig; Chuang-Stein, Christy; McSorley, Paul; Schwartz, Jeffrey; Archibald, Donald G; Perahia, David G; Detke, Michael J; Alphs, Larry

Mallinckrodt, Craig; Chuang-Stein, Christy; McSorley, Paul; Schwartz, Jeffrey; Archibald, Donald G; Perahia, David G; Detke, Michael J; Alphs, Larry.

Affiliation

Mallinckrodt C; Eli Lilly and Company, Indianapolis, IN 46285, USA. cmallinc@lilly.com

Pharm Stat ; 6(1): 9-22, 2007.

Article in En | MEDLINE | ID: mdl-17238129

Subject(s)

Antidepressive Agents/therapeutic use; Depressive Disorder, Major/drug therapy; Research Design; Data Interpretation, Statistical; Double-Blind Method; Europe; Humans; North America; Recurrence; Time Factors; Treatment Outcome

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Research Design / Depressive Disorder, Major / Antidepressive Agents Type of study: Clinical_trials / Guideline Limits: Humans Country/Region as subject: America do norte / Europa Language: En Journal: Pharm Stat Journal subject: FARMACOLOGIA Year: 2007 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links